These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 24267266)

  • 1. Gut microbiota metabolism of L-carnitine and cardiovascular risk.
    Ussher JR; Lopaschuk GD; Arduini A
    Atherosclerosis; 2013 Dec; 231(2):456-61. PubMed ID: 24267266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
    Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
    Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis.
    Koeth RA; Wang Z; Levison BS; Buffa JA; Org E; Sheehy BT; Britt EB; Fu X; Wu Y; Li L; Smith JD; DiDonato JA; Chen J; Li H; Wu GD; Lewis JD; Warrier M; Brown JM; Krauss RM; Tang WH; Bushman FD; Lusis AJ; Hazen SL
    Nat Med; 2013 May; 19(5):576-85. PubMed ID: 23563705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.
    Trøseid M; Hov JR; Nestvold TK; Thoresen H; Berge RK; Svardal A; Lappegård KT
    Metab Syndr Relat Disord; 2016 May; 14(4):197-201. PubMed ID: 27081744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contributory role of gut microbiota in cardiovascular disease.
    Tang WH; Hazen SL
    J Clin Invest; 2014 Oct; 124(10):4204-11. PubMed ID: 25271725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans.
    Koeth RA; Lam-Galvez BR; Kirsop J; Wang Z; Levison BS; Gu X; Copeland MF; Bartlett D; Cody DB; Dai HJ; Culley MK; Li XS; Fu X; Wu Y; Li L; DiDonato JA; Tang WHW; Garcia-Garcia JC; Hazen SL
    J Clin Invest; 2019 Jan; 129(1):373-387. PubMed ID: 30530985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice.
    Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM
    J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis.
    Drosos I; Tavridou A; Kolios G
    Metabolism; 2015 Apr; 64(4):476-81. PubMed ID: 25676802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of an in-vitro batch fermentation (human colon) model for investigating mechanisms of TMA production from choline, L-carnitine and related precursors by the human gut microbiota.
    Day-Walsh P; Shehata E; Saha S; Savva GM; Nemeckova B; Speranza J; Kellingray L; Narbad A; Kroon PA
    Eur J Nutr; 2021 Oct; 60(7):3987-3999. PubMed ID: 33934200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metaorganismal nutrient metabolism as a basis of cardiovascular disease.
    Brown JM; Hazen SL
    Curr Opin Lipidol; 2014 Feb; 25(1):48-53. PubMed ID: 24362355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.
    Li D; Kirsop J; Tang WH
    Curr Diab Rep; 2015 Sep; 15(9):63. PubMed ID: 26208694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
    Zeisel SH; Warrier M
    Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary modification of the microbiome affects risk for cardiovascular disease.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2013 Jun; 16(3):241-4. PubMed ID: 23656565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
    Romano KA; Vivas EI; Amador-Noguez D; Rey FE
    mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases.
    He S; Jiang H; Zhuo C; Jiang W
    Cardiovasc Toxicol; 2021 Aug; 21(8):593-604. PubMed ID: 34003426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.
    Collins HL; Drazul-Schrader D; Sulpizio AC; Koster PD; Williamson Y; Adelman SJ; Owen K; Sanli T; Bellamine A
    Atherosclerosis; 2016 Jan; 244():29-37. PubMed ID: 26584136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine
    Canyelles M; Tondo M; Cedó L; Farràs M; Escolà-Gil JC; Blanco-Vaca F
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease.
    Wang Z; Klipfell E; Bennett BJ; Koeth R; Levison BS; Dugar B; Feldstein AE; Britt EB; Fu X; Chung YM; Wu Y; Schauer P; Smith JD; Allayee H; Tang WH; DiDonato JA; Lusis AJ; Hazen SL
    Nature; 2011 Apr; 472(7341):57-63. PubMed ID: 21475195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO.
    Koeth RA; Levison BS; Culley MK; Buffa JA; Wang Z; Gregory JC; Org E; Wu Y; Li L; Smith JD; Tang WHW; DiDonato JA; Lusis AJ; Hazen SL
    Cell Metab; 2014 Nov; 20(5):799-812. PubMed ID: 25440057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.